Clinical Investigation : Genitourinary Cancer Role of Diffusion-Weighted Magnetic Resonance Imaging in Predicting Sensitivity to Chemoradiotherapy in Muscle-Invasive Bladder Cancer
暂无分享,去创建一个
Kazutaka Saito | Kazunori Kihara | Yasuhisa Fujii | Fumitaka Koga | Hitoshi Masuda | Soichiro Yoshida | Hajime Tanaka | K. Kihara | Hajime Tanaka | S. Yoshida | F. Koga | Y. Fujii | S. Kawakami | Yoshinobu Komai | Chikako Ishii | Satoru Kawakami | H. Masuda | Shuichiro Kobayashi | Hiroshi Tanaka | C. Ishii | Shuichiro Kobayashi | Y. Komai | K. Saito | Hiroshi Tanaka | Hiroshi Tanaka | Hiroshi Tanaka | Hajime Tanaka
[1] H. Sandler,et al. Current status of radiation therapy for bladder cancer , 2010, Expert review of anticancer therapy.
[2] Jürgen Griebel,et al. Tumor microcirculation and diffusion predict therapy outcome for primary rectal carcinoma. , 2003, International journal of radiation oncology, biology, physics.
[3] J. Dunst,et al. Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] F. Koga,et al. Negative p53/Positive p21 Immunostaining Is a Predictor of Favorable Response to Chemotherapy in Patients with Locally Advanced Bladder Cancer , 2000, Japanese journal of cancer research : Gann.
[5] K. Kihara,et al. Initial experience of diffusion-weighted magnetic resonance imaging to assess therapeutic response to induction chemoradiotherapy against muscle-invasive bladder cancer. , 2010, Urology.
[6] C. Rödel,et al. Trimodality treatment and selective organ preservation for bladder cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] K. Kihara,et al. Usefulness of diffusion-weighted MRI in diagnosis of upper urinary tract cancer. , 2011, AJR. American journal of roentgenology.
[8] C. Rödel,et al. Apoptosis, p53, bcl-2, and Ki-67 in invasive bladder carcinoma: possible predictors for response to radiochemotherapy and successful bladder preservation. , 2000, International journal of radiation oncology, biology, physics.
[9] Yanlei Li,et al. Diffusion-weighted imaging in predicting and monitoring the response of uterine cervical cancer to combined chemoradiation. , 2009, Clinical radiology.
[10] Stephan E Maier,et al. Pretreatment prediction of brain tumors' response to radiation therapy using high b-value diffusion-weighted MRI. , 2004, Neoplasia.
[11] K. Kihara,et al. Favourable outcomes of patients with clinical stage T3N0M0 bladder cancer treated with induction low‐dose chemo‐radiotherapy plus partial or radical cystectomy vs immediate radical cystectomy: a single‐institutional retrospective comparative study , 2009, BJU international.
[12] P. Choyke,et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. , 2009, Neoplasia.
[13] K. Naito,et al. Bax to Bcl-2 ratio and Ki-67 index are useful predictors of neoadjuvant chemoradiation therapy in bladder cancer. , 2004, Japanese journal of clinical oncology.
[14] Kazutaka Saito,et al. Diagnostic performance of diffusion-weighted magnetic resonance imaging in bladder cancer: potential utility of apparent diffusion coefficient values as a biomarker to predict clinical aggressiveness , 2011, European Radiology.
[15] L. Neckers,et al. ErbB2 and NFκB Overexpression as Predictors of Chemoradiation Resistance and Putative Targets to Overcome Resistance in Muscle-Invasive Bladder Cancer , 2011, PloS one.
[16] H. Sandler,et al. Overview of bladder cancer trials in the Radiation Therapy Oncology Group , 2003, Cancer.
[17] D. Collins,et al. Diffusion-weighted MRI in the body: applications and challenges in oncology. , 2007, AJR. American journal of roentgenology.
[18] K. Kihara,et al. Low-dose chemoradiotherapy followed by partial or radical cystectomy against muscle-invasive bladder cancer: an intent-to-treat survival analysis. , 2008, Urology.
[19] MULTI-INSTITUTIONAL VALIDATION OF THE PREDICTIVE VALUE OF KI-67 LABELING INDEX IN PATIENTS WITH URINARY BLADDER CANCER , 2009 .
[20] L. Häberle,et al. 15-year survival rates after transurethral resection and radiochemotherapy or radiation in bladder cancer treatment. , 2011, Anticancer research.